一种经过重新设计的胺素,设计用于双重D-Ala-D-ala和D-Ala-D-Lac结合,对抗抗胺素耐药细菌表现出强大的抗菌活性
Jian Xie1, Joshua G Pierce, Robert C James
1Department of Chemistry, The Skaggs Institute for Chemical Biology, La Jolla, California 92037, United States.
Journal of the American Chemical Society
|August 10, 2011
概括
一种新型的万科胺衍生物,[Ψ[C[(NH) NH]Tpg(4) ]万科胺,通过与d-Ala-d-Ala和d-Ala-d-Lac目标结合,恢复了对抗万科胺耐药细菌的抗菌活性.
科学领域:
- 微生物学 微生物学
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
背景情况:
- 细菌中万科米辛耐药性是全球健康的重大威胁.
- 耐药细菌改变了它们的细胞壁前体,降低了万科迈的疗效.
- 丁糖甘中的d-Ala-d-Lac修饰是抗万科米辛耐药性的关键机制.
研究的目的:
- 设计和合成一种具有双重结合能力的万科米辛衍生物.
- 为了恢复抗菌活性对抗抗菌素耐药性细菌菌株.
- 开发一种新的治疗策略,用于对抗耐药性感染.
主要方法:
- [Ψ[C(NH) NH]Tpg(4)]万科米辛的化学合成.
- 使用d-Ala-d-Ala和d-Ala-d-Lac配体进行结合亲和度测试.
- 抗菌活性测试对抗万科米辛耐药性肠球菌 (VRE).
主要成果:
- 这种新型衍生品对d-Ala-d-Ala和d-Ala-d-Lac.Lac.都表现出强烈的结合.
- 与万科酸甘相比,与d-Ala-d-Lac的结合亲和力显著增强.
- 针对VanA VRE,证明了强大的抗微生物活性,最小抑制度 (MIC) 为0.31微克/毫升.
结论:
- 范科米中单个原子的修饰可以克服抗性机制.
- 设计的衍生品为治疗耐万科米细菌感染提供了一个有前途的方法.
- 这一战略为开发下一代抗生素提供了合理的基础.
相关概念视频
Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antibiotic Selection
Overview
Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...


